MANAGEMENT OF COMORBIDITIES IN CHRONIC KIDNEY DISEASE: A PROSPECTIVE OBSERVATIONAL STUDY

Pranavi Dasari, Venkateshwarlu K, Raj Kumar Venisetty
unpublished
Objective: The study was aimed to manage the comorbidities in chronic kidney disease (CKD) in multi-super specialty hospital. This is a prospective observational study done for a period of nine months from January to September 2012 at the inpatient block of Global hospital at Lakdi-ka-pool in Hyderabad. Methods: Demographic details of patient, present disease condition, drugs prescribed was collected from case report and their care takers were interviewed for their past medication history,
more » ... ation history, family history. Results: Out of 150 cases, 108 were males (72 %), 42 were females (28 %). Of them age difference in the range 54-62 are (22%) than other age groups.114 (76%) patients were at stage V whereas, 27(18%) and 9(6%) were at IV and III stage respectively. Patients with highest percentage of co morbidity were 26% of hypertension (HTN)+diabetes mellitus (DM), only HTN 23.3% and 15.3% of HTN+DM+CAD. Out of 119 HTN patients combination therapy of drugs was prescribed in 62(52.1%), individual drug therapy of Calcium channel blocker in highest number 72(60.5%), Beta blockers 66(55.4%). For management of DM insulin therapy was prescribed. For patients with coronary artery disease (CAD) Anti-platelet therapy were given in 34(54.8%) patients. To treat anemia erythropoietin was given in 70(47.2%), for dyslipidemia, atorvastatin was prescribed in 46(90.1%). Conclusion: CKD is comorbid with HTN, DM and CAD and for the management of this it require a standard guidelines.
fatcat:rea67w6efzb2xik5kkdx5cxopi